Resultados y vida financieraAgroalimentación
Quarterly financial reporting / Third quarter financial report
09/11/2026 18:00
AMFPublicación inmediata
Saint-Dolay, France, November 6, 2026 – 6:00 p.m. CET – Vinpai (ISIN FR001400AXT1; ticker symbol: ALVIN), a specialist in the design, manufacture, and marketing of functional ingredients derived from algae and plants for the food and cosmetics industries (“Vinpai” or the “Company”), today…
Press Release
Vinpai reports revenue for the third quarter of 2026
Saint-Dolay, France, November 6, 2026 – 6:00 p.m. CET – Vinpai (ISIN FR001400AXT1; ticker symbol: ALVIN), a specialist in the design, manufacture, and marketing of functional ingredients derived from algae and plants for the food and cosmetics industries (“Vinpai” or the “Company”), today announced its revenue for the third quarter and the first nine months of fiscal year 2026.
.
Philippe Le Ray, CEO and Co-founder, stated, “The first nine months of the year were marked by a collapse in our sales in Algeria, due to circumstances beyond the Company’s control. With the support of our majority shareholder, and in order to reduce our excessive dependence on this geographic region , we are refocusing our sales efforts on other geographic regions and on product lines with higher value-added. I am confident that we will emerge from this difficult period with a more resilient organization and that we will return to a path of growth in the coming months.”
Third Quarter 2026 Results
Revenue – in €k 2025 2026 % Change
3rd Quarter 2,365 1,050 -55.6%
Total for 9 months 7,262 4,875 -32.9%
In the third quarter of 2026, revenue totaled €1,050k, down 55.6% from €2,365k in the third quarter of 2025. For the first nine months of fiscal year 2026, revenue was down 32.9% to €4,875k.
The decline in revenue is a direct result of the extension into the third quarter of the sudden halt in all shipments to Algeria, following the implementation of import controls by that country that occurred during the second quarter.
The order backlog remained stable at €2.8 million as of September 30, 2026 thereby preserving the revenue for the fourth quarter outlook.
Strategy and Outlook
Encouraged by early signs of a recovery in business, Vinpai is aiming to return to growth during the coming financial year whilst continuing the integration with CAMLIN Fine Sciences Limited, particularly with regard to its sales organisation. The Company will also make its operating cost structure more flexible so that it can adapt more effectively to changes in business activity.
Next financial announcement: 2026 annual revenue, on January 27, 2027, after market close
About Vinpai
Vinpai, a subsidiary of the CAMLIN Fine Science Limited group, is an “ingredien’tech” company specializing in the design, manufacture, and marketing of functional ingredients derived from algae, plants, minerals, and fibers, offering manufacturers natural alternatives to chemical additives. Positioned in the most promising market segments, Vinpai currently supports manufacturers in the food and beverage industry—its traditional market—as well as in the cosmetics and nutraceuticals sectors, thanks to its cross-technology expertise, which enables them to enhance the nutritional qualities of their finished products. The combination and blending of food ingredients and additives enable manufacturers to accelerate product development, optimize production costs, and boost profitability. Spread across two sites in Saint- Dolay and Rieux (Morbihan), near the port of Saint-Nazaire, Vinpai has developed more than 3,500 formulations and currently employs 39 people. In 2025, the company generated revenue of €10.2 million, with more than 78% coming from exports, and is established in more than 36 countries.